Female, n (%)
|
13 (65.0)
|
14 (60.9)
|
0.780
|
Age (y)a
|
66.5 ± 11.9
|
66.7 ± 13.6
|
0.969
|
Having previous stroke, n (%)
|
2 (10.0)
|
6 (26.1)
|
0.250
|
Post-stroke duration (m)a
|
10.2 ± 14.9
|
7.7 ± 11.6
|
0.547
|
Duration of PSD onset (m)a
|
4.9 ± 12.0
|
4.7 ± 10.7
|
0.953
|
Having antidepressant treatment at study entry, n (%)c
| | |
0.222
|
Fluoxetine (FLX)
|
14 (70.0)
|
15 (65.2)
| |
Other antidepressant agentsd
|
5 (25.0)
|
3 (13.0)
| |
Previous acupuncture experience, n (%)
|
14 (70.0)
|
13 (56.5)
|
0.362
|
Baseline MMSEa
|
23.5 ± 4.4
|
24.8 ± 4.8
|
0.354
|
Baseline HAMD-17a
|
28.1 ± 7.0
|
25.8 ± 5.0
|
0.225
|
Baseline CGI-Sa
|
4.8 ± 0.8
|
4.9 ± 0.5
|
0.580
|
Baseline BIa
|
37.8 ± 10.7
|
37.7 ± 11.3
|
0.975
|